Keyphrases
Therapeutic Approaches
100%
Type 1 Diabetes Mellitus (T1DM)
100%
Type I Diabetes
100%
Alpha-1 Antitrypsin
100%
Mechanistic Evidence
100%
Adverse Effects
33%
Insulin
33%
Tissue Damage
33%
Antibacterial Activity
33%
4-fold
33%
Clinical Trials
33%
High Dose
33%
Immune Response
33%
Therapeutic Target
33%
Immunomodulatory
33%
Safety Profile
33%
Insulin Production
33%
Antitrypsin
33%
Islet Function
33%
Acute Phase Response
33%
Placebo-controlled Trial
33%
Wound Healing
33%
Excessive Inflammation
33%
Cellular Injury
33%
Medical Research
33%
Lung Ischemia
33%
Autoimmunity
33%
Adaptive Immune Response
33%
Tissue Repair
33%
Antiviral Activity
33%
Synthetic Molecules
33%
Selectivity Control
33%
Circulating Proteins
33%
Ischemic Heart Disease
33%
Multiple Levels
33%
Genetic Deficiency
33%
Renal Ischemia-reperfusion Injury
33%
Pancreatic Islet Cells
33%
Endogenous Substances
33%
Other-report
33%
Rare Occurrence
33%
Type 1 Diabetes Patients
33%
Insulin Therapy
33%
Immunology and Microbiology
Antibacterial Activity
100%
Adaptive Immune System
100%
Immune Response
100%
Immunosuppressive Drug
100%
Alpha 1-Antitrypsin
100%
Acute Phase Response
100%
Autoimmunity
100%
Reperfusion
100%
Wound Healing
100%
Antiviral Activity
100%
Cell Damage
100%
Tissue Repair
100%
Medicine and Dentistry
Insulin Dependent Diabetes Mellitus
100%
Alpha 1 Antitrypsin
100%
Anti-Inflammatory Drug
50%
Adverse Event
25%
Placebo
25%
Tissue Injury
25%
Adaptive Immunity
25%
Clinical Trial
25%
Immune Response
25%
Apoplexy
25%
Pancreatic Islet
25%
Trypsin Inhibitor
25%
Immunosuppressive Drug
25%
Acute Phase Response
25%
Autoimmunity
25%
Medical Research
25%
Ischemic Heart Disease
25%
Antiviral Activity
25%
Antibacterial Activity
25%
Cell Damage
25%
Kidney Ischemia
25%
Insulin Treatment
25%
Tissue Repair
25%
Reperfusion Injury
25%
Cytoprotective Agent
25%
Wound Healing
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha 1 Antitrypsin
100%
Insulin Dependent Diabetes Mellitus
100%
Anti-Inflammatory Drug
50%
Tissue Injury
25%
Combination Therapy
25%
Antibacterial Activity
25%
Inflammation
25%
Clinical Trial
25%
Adverse Event
25%
Placebo
25%
Reperfusion Injury
25%
Trypsin Inhibitor
25%
Immunosuppressive Agent
25%
Antiviral Activity
25%
Cellular Injury
25%
Wound Healing
25%
Cytoprotective Agent
25%
Kidney Ischemia
25%
Tissue Repair
25%
Ischemic Heart Disease
25%